These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19589397)

  • 1. Anti-angiogenic effect of caffeic acid on retinal neovascularization.
    Kim JH; Lee BJ; Kim JH; Yu YS; Kim KW
    Vascul Pharmacol; 2009 Oct; 51(4):262-7. PubMed ID: 19589397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression.
    Kim JH; Lee BJ; Kim JH; Yu YS; Kim MY; Kim KW
    Eur J Pharmacol; 2009 Aug; 615(1-3):150-4. PubMed ID: 19470386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitriol is a potent inhibitor of retinal neovascularization.
    Albert DM; Scheef EA; Wang S; Mehraein F; Darjatmoko SR; Sorenson CM; Sheibani N
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2327-34. PubMed ID: 17460298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
    Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin inhibits the retinal neovascularization in vitro and in vivo.
    Chikaraishi Y; Matsunaga N; Shimazawa M; Hara H
    Exp Eye Res; 2008 Jan; 86(1):131-7. PubMed ID: 18031740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
    Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
    Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.
    Brooks SE; Gu X; Samuel S; Marcus DM; Bartoli M; Huang PL; Caldwell RB
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):222-8. PubMed ID: 11133872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation.
    Kim JH; Kim MH; Jo DH; Yu YS; Lee TG; Kim JH
    Biomaterials; 2011 Mar; 32(7):1865-71. PubMed ID: 21145587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis.
    Zhou L; Zhang T; Lu B; Yu Z; Mei X; Abulizi P; Ji L
    J Ethnopharmacol; 2016 Aug; 189():117-25. PubMed ID: 27196298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
    Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubedown-1 (Tbdn-1) suppression in oxygen-induced retinopathy and in retinopathy of prematurity.
    Gendron RL; Good WV; Miskiewicz E; Tucker S; Phelps DL; Paradis H
    Mol Vis; 2006 Feb; 12():108-16. PubMed ID: 16518308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
    Zhang M; Yang Y; Yan M; Zhang J
    Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).
    Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo.
    Yoo MH; Hyun HJ; Koh JY; Yoon YH
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4780-7. PubMed ID: 16303979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.